The trajectory of Sildenafil presents a interesting case for investors in the pharmaceutical sector. While initially a tremendous success, generating billions, the patent end get more info and the subsequent entry of off-brand alternatives have considerably impacted income. This poses questions about the long-term sustainability of related medicati